- Home
- ORIC vs VINP Comparison
ORIC vs VINP Comparison
Compare ORIC & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- VINP
- Stock Information
- Founded
- ORIC 2014
- VINP 2009
- Country
- ORIC United States
- VINP Brazil
- Employees
- ORIC N/A
- VINP N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- VINP Investment Managers
- Sector
- ORIC Health Care
- VINP Finance
- Exchange
- ORIC Nasdaq
- VINP Nasdaq
- Market Cap
- ORIC 362.9M
- VINP 593.2M
- IPO Year
- ORIC 2020
- VINP 2021
- Fundamental
- Price
- ORIC $10.71
- VINP $9.48
- Analyst Decision
- ORIC Strong Buy
- VINP Strong Buy
- Analyst Count
- ORIC 9
- VINP 2
- Target Price
- ORIC $18.29
- VINP $13.25
- AVG Volume (30 Days)
- ORIC 987.5K
- VINP 55.0K
- Earning Date
- ORIC 08-11-2025
- VINP 08-06-2025
- Dividend Yield
- ORIC N/A
- VINP 6.76%
- EPS Growth
- ORIC N/A
- VINP N/A
- EPS
- ORIC N/A
- VINP 0.38
- Revenue
- ORIC N/A
- VINP $126,696,258.00
- Revenue This Year
- ORIC N/A
- VINP $70.28
- Revenue Next Year
- ORIC N/A
- VINP $14.37
- P/E Ratio
- ORIC N/A
- VINP $25.27
- Revenue Growth
- ORIC N/A
- VINP 57.51
- 52 Week Low
- ORIC $3.90
- VINP $8.66
- 52 Week High
- ORIC $14.67
- VINP $11.62
- Technical
- Relative Strength Index (RSI)
- ORIC 67.12
- VINP 44.44
- Support Level
- ORIC $10.42
- VINP $9.43
- Resistance Level
- ORIC $11.14
- VINP $9.94
- Average True Range (ATR)
- ORIC 0.59
- VINP 0.20
- MACD
- ORIC -0.08
- VINP -0.00
- Stochastic Oscillator
- ORIC 79.49
- VINP 13.33
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.